Close Menu

NEW YORK (GenomeWeb) – Germany's Merck KGaA today announced the completion of its $17 billion acquisition of Sigma-Aldrich, following approval from the European Commission.

The deal creates a science sector giant that will "cover every step of the biotech production chain," Merck said in a statement. The company will have around 50,000 employees in 67 countries, working at 72 manufacturing sites worldwide, with combined pro forma full-year life science sales of €4.6 billion in 2014 and expected sales between €12.6 billion and €12.8 billion in 2015.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.